研究者
J-GLOBAL ID：202301010312170071   更新日: 2024年10月31日

中村 俊文

Nakamura Toshifumi
競争的資金等の研究課題 (1件)：
  • 2017 - 2019 尿細管MR機能との比較を通じた腸管MRの血圧代謝関連病態における新たな意義の解明
論文 (11件)：
  • Nakamura T, Hayashi K. Accumulating evidence suggests the potential of selective adrenal artery embolization as a standard treatment for primary aldosteronism. Hypertension research : official journal of the Japanese Society of Hypertension. 2024
  • Stefanny M Figueroa, Jean-Philippe Bertocchio, Toshifumi Nakamura, Soumaya El-Moghrabi, Frédéric Jaisser, C. A. Amador. The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice. Pharmaceutics. 2023. 15. 5. 1373-1373
  • Rie Jo, Hirotaka Shibata, Isao Kurihara, Kenichi Yokota, Sakiko Kobayashi, Ayano Murai-Takeda, Yuko Mitsuishi, Takeshi Hayashi, Toshifumi Nakamura, Hiroshi Itoh. Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification. Hypertension Research. 2022. 46. 1. 19-31
  • Van Tuan Nguyen, Qui Trung Ngo, Roberto Palacios Ramirez, Toshifumi Nakamura, Nicolette Farman, Sélim Aractingi, Frederic Jaisser. The myeloid mineralocorticoid receptor regulates dermal angiogenesis and inflammation in glucocorticoid-induced impaired wound healing. British Journal of Pharmacology. 2022. 179. 23. 5222-5232
  • Toshifumi Nakamura, Benjamin Bonnard, Palacios-Ramirez, R, Amaya Fernández-Celis, Frédéric Jaisser, Natalia López-Andrés. Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury. International Journal of Molecular Sciences. 2022. 23. 12. 6680-6680
もっと見る
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM